Repare Therapeutics

Last updated: January 20, 2024

CEO Lloyd Segal
CEO Lloyd Segal
Country: Canada | Funding: $251.7M (+)

Website: http://www.reparerx.com/

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.